Nizonide

📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.

Why order from MedsBase

Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging — no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor — never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.

What Nizonide is for

Nizonide is a thiazolide antiprotozoal manufactured by Cipla. The active ingredient nitazoxanide has a uniquely broad spectrum against intracellular and luminal protozoa, certain helminths, anaerobic bacteria, and a number of RNA viruses. In traveller’s-diarrhoea and tropical-medicine practice it is most commonly used for:

• Giardiasis — first-line in many countries; alternative to metronidazole and tinidazole. Better tolerated (no disulfiram-like reaction with alcohol) and shorter 3-day course.
• Cryptosporidiosis — the only FDA-approved drug for this infection in immunocompetent adults and children. In severe cryptosporidiosis associated with HIV/AIDS the response is partial — restoration of CD4 count via ART is the central intervention.
• Amoebiasis (intestinal, off-label) — good activity against Entamoeba histolytica; metronidazole or tinidazole remain preferred for invasive disease.
• Other protozoa — Blastocystis hominis, Cyclospora, Isospora in selected contexts.
• Helminths (off-label) — Hymenolepis nana (dwarf tapeworm), Ascaris lumbricoides, Trichuris trichiura; albendazole/mebendazole remain preferred first-line.
• Viral gastroenteritis — clinical-trial evidence supports modest reduction in symptom duration in rotavirus and norovirus diarrhoea (Rossignol JAMA 2009; Rossignol Lancet 2006). Not standard of care; consider in severe or prolonged viral illness.
• Recurrent Clostridioides difficile infection (off-label salvage) — small case series only; vancomycin and fidaxomicin remain first-line.

How Nizonide works

Nitazoxanide is a prodrug rapidly hydrolysed to its active metabolite tizoxanide in the gut and liver. The mechanism is unique among anti-infectives: it inhibits the pyruvate:ferredoxin oxidoreductase (PFOR) enzyme required for anaerobic energy metabolism in protozoa, anaerobic bacteria, and certain helminths. Because mammalian cells use aerobic mitochondrial metabolism instead, the drug is selectively toxic to the pathogen. Antiviral activity against rotavirus, norovirus, influenza, and hepatitis B/C is mediated through different pathways including interference with viral protein maturation.

Dosing

Side effects

• Bright greenish-yellow urine — a harmless and characteristic effect of the tizoxanide metabolite. Resolves within 24–48 hours of stopping the course.
• Common (1–10%) — abdominal pain, diarrhoea (paradoxically), headache, nausea.
• Uncommon — vomiting, dyspepsia, skin rash.
• Rare — elevated liver enzymes (usually self-limiting), hypersensitivity reactions.

Drug interactions

Nitazoxanide and tizoxanide are extensively protein-bound (> 99 %). Caution is warranted with other highly protein-bound drugs in narrow therapeutic windows:

• Warfarin — competition for albumin binding can transiently raise free-warfarin levels; monitor INR closely if co-administered.
• Phenytoin — similar mechanism; consider level monitoring during co-treatment.
• Antacids and bile-acid sequestrants — no clinically significant interaction reported, but separate dosing by 2 hours as a precaution.
• CYP enzymes — nitazoxanide is not a significant CYP substrate or inhibitor at therapeutic doses; CYP-mediated interactions are uncommon.

Contraindications and cautions

• Pregnancy — limited human data. FDA Pregnancy Category B (animal data reassuring; no controlled human studies). Avoid in first trimester unless benefit clearly outweighs uncertain risk.
• Breastfeeding — limited data on excretion in breast milk. Short courses generally compatible; avoid prolonged dosing where possible.
• Children < 1 year — safety not established; specialist supervision only.
• Severe hepatic impairment — limited data; specialist supervision.
• Severe renal impairment (CrCl < 30) — limited data; specialist supervision.

Storage

Store below 25 °C in the original blister, away from moisture and direct sunlight. Keep out of reach of children. Do not use after expiry — antiprotozoal potency degrades.

Frequently Asked Questions

Is Nizonide first-line for traveller’s diarrhoea?

No. Most acute traveller’s diarrhoea is bacterial (ETEC, Campylobacter, Shigella, Salmonella) — for which a single-dose azithromycin or a 1–3 day fluoroquinolone course is first-line. Nizonide becomes appropriate when stool testing identifies a protozoal cause, or in chronic / recurrent / antibiotic-failed diarrhoea suggestive of cryptosporidium or giardia.

Why does my urine turn bright yellow-green on Nizonide?

Tizoxanide, the active metabolite, has an intense yellow chromophore that is excreted renally. The colour is harmless and a normal expected effect — it does not indicate liver or kidney problems. It clears within 24–48 hours of finishing the course.

Can I take Nizonide if I am pregnant?

Human pregnancy data are limited. The US FDA classifies nitazoxanide as Pregnancy Category B (no animal evidence of harm, no controlled human studies). For confirmed giardiasis or cryptosporidiosis in pregnancy, paromomycin (non-absorbed aminoglycoside) is often preferred in the first trimester. Nitazoxanide may be used in second/third trimester after risk-benefit discussion with an obstetrician.

Does Nizonide cure cryptosporidiosis in HIV/AIDS?

Partial response only. In immunocompetent adults nitazoxanide reliably shortens cryptosporidial diarrhoea. In severe immunocompromise (CD4 < 200), response rates are lower and the central intervention is restoration of CD4 count via effective antiretroviral therapy. Higher doses (1000 mg BID) and longer courses (≥ 14 days) are used in HIV under specialist supervision.

Does Nizonide work against COVID-19?

No. Early small studies suggested in-vitro activity but large randomised controlled trials in symptomatic outpatients (PROMINENT-NZX 2022, Rocco 2023) showed no clinically meaningful benefit on viral load, symptom duration, or hospitalisation. Routine use for COVID-19 is not supported.

How long until symptoms improve?

For giardiasis and cryptosporidiosis in immunocompetent adults, most patients notice symptom improvement within 24–72 hours of starting therapy, with full resolution by the end of the 3-day course or shortly after. Persistent diarrhoea beyond day 5 should prompt re-evaluation — possible alternative diagnosis, treatment failure (consider drug exposure with food), or co-infection.

Can I drink alcohol while taking Nizonide?

Yes. Unlike metronidazole and tinidazole, nitazoxanide does not cause a disulfiram-like reaction with alcohol. Modest alcohol intake during a 3-day course is not dangerous, though hydration, gut rest, and avoiding alcohol while diarrhoea is active are sensible regardless.

Why must I take it with food?

Nitazoxanide is poorly water-soluble. Taking it on an empty stomach gives roughly half the systemic exposure compared with taking it with food — particularly fatty food. Sub-therapeutic absorption is the most common reason for treatment failure. Always take both daily doses with a meal, ideally one containing some fat.

Can I give Nizonide to my child?

Yes, from age 1. Paediatric dosing is age-banded: 1–3 years 100 mg BID; 4–11 years 200 mg BID; 12+ years adult 500 mg BID. Cipla also makes nitazoxanide as a paediatric oral suspension at 100 mg / 5 ml. Safety in infants < 1 year is not established.

How does Nizonide compare with metronidazole for giardiasis?

Comparable cure rates (around 75–85 %) in head-to-head trials. Nitazoxanide advantages: shorter 3-day course (vs 5–7 days for metronidazole), no disulfiram-like alcohol reaction, no metallic taste, generally better tolerated. Metronidazole advantages: more market familiarity, lower cost, available in most healthcare settings. Either is reasonable first-line.

Can Nizonide treat amoebiasis?

Yes for intestinal/luminal amoebiasis (3-day course), with cure rates comparable to metronidazole. For invasive disease (amoebic dysentery, hepatic abscess), metronidazole or tinidazole — followed by a luminal agent like paromomycin to clear cysts — remain the preferred regimen. Always investigate suspected amoebiasis with stool antigen or PCR plus serology when liver involvement is possible.

Other Traveller’s Diarrhoea & Antibiotic Options

• Althrocin (erythromycin 250/500 mg) — alternative for Campylobacter coverage
• Augmentin (amoxicillin + clavulanate) — for selected bacterial GI infections
• Cendox (doxycycline 100 mg) — broad-spectrum traveller-medicine antibiotic
• Medical Emergency Kit — 8-drug travel pack
• Metrogyl (metronidazole 200/400 mg) — alternative for giardia / amoebiasis
• Tiniba (tinidazole 500/1000 mg) — single-dose option for giardia

More options in Diarrhoea Treatment

Ranked by recent MedsBase order volume — what other customers in this category are picking.

Imodium

US$42.00 – US$163.00Rango de precios: desde US$42.00 hasta US$163.00